Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$32.1M
-46.6% from 2023
Prescriptions
349K
$91.85 per claim
Patients
71K
35,158 prescribers
Total spending, 2024
$32.1M
$452.10 per patient
Medicare prescription drug plans paid $32.1M for Roflumilast in 2024, for 349,305 prescriptions and refills to 70,959 patients (down 46.6% from 2023). The average cost per claim was $91.85.
New York had the highest Medicare cost for Roflumilast in 2024: $2.3M for 21,749 claims, followed by California ($2.1M).
null, internal medicine, had the highest Medicare cost for Roflumilast in 2024: 908 claims costing $209K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| 1710074026 | Internal Medicine | 908 | 252 | $209K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 648 | 131 | $51K |
| Ganesha Santhyadka Bangor, ME |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 13,177 | 30,776 | 21,876 | $10.4M |
| 2023 | 31,879 | 275,997 | 59,460 | $60.1M |
| 2024 | 35,158 | 349,305 | 70,959 | $32.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 536 |
| 96 |
| $51K |
| Dragos G Zanchi Brandon, FL | Pulmonary Disease | 610 | 124 | $46K |
| Shahla G Naoman Batesville, AR | Pulmonary Disease | 409 | 68 | $44K |
| Stephen P Chen Monterey Park, CA | Critical Care (Intensivists) | 339 | 58 | $42K |
| Johnathan R Grant Vincennes, IN | Pulmonary Disease | 550 | 91 | $38K |
| Mir-Omar Ali Clayton, NC | Pulmonary Disease | 723 | 181 | $36K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 234 | 69 | $36K |
| Danish Thameem Champaign, IL | Internal Medicine | 274 | 59 | $35K |
| Usman A Cheema Galesburg, IL | Pulmonary Disease | 209 | 46 | $33K |
| Arthur Cacacho Olean, NY | Internal Medicine | 427 | 86 | $33K |
| Mohammad Tariq Kokomo, IN | Pulmonary Disease | 556 | 106 | $32K |
| Syed S Ahmed Palmdale, CA | Internal Medicine | 308 | 62 | $31K |
| Kenneth K Sha Flushing, NY | Pulmonary Disease | 281 | 40 | $31K |
| Jingli Ma Melrose, MA | Internal Medicine | 297 | 63 | $31K |
| Ahmad M Ibrahimbacha Cleveland, TN | Pulmonary Disease | 276 | 78 | $30K |
| Miguel A Rodriguez Springfield, MA | Pulmonary Disease | 304 | 74 | $29K |
| Salaam T Alobeidy Galloway, NJ | Pulmonary Disease | 202 | 49 | $29K |
| Maria Carmina C Garcia Johnson City, TN | Pulmonary Disease | 235 | 55 | $28K |
| Umer H Siddiqui Washington, MO | Pulmonary Disease | 351 | 73 | $28K |
| Pasquale Picco Hornell, NY | Internal Medicine | 177 | 42 | $27K |
| Robert A Pensler Wyandotte, MI | Pulmonary Disease | 322 | 77 | $26K |
| Timothy J Killeen Temecula, CA | Internal Medicine | 196 | 56 | $26K |
| Clyde O Southwell Hendersonville, TN | Pulmonary Disease | 222 | 64 | $26K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Camber Pharmace | 94,718 | $8.8M |
| Novadoz Pharmac | 88,617 | $8.4M |
| Zydus Pharmaceu ZYDUSLIFE.NS | 81,971 | $7.6M |
| Aurobindo Pharm AUROPHARMA.NS | 36,795 | $2.8M |
| Solco Healthcar | 23,692 | $2.4M |
| Mylan VTRS | 13,031 | $1.3M |
| Micro Labs USA, | 10,461 | $764K |
| Major Pharmaceu | 88 | $8,126 |